fbpx

Learn about the effects of a study drug for participants with NASH

The purpose of this research is to determine whether an investigational drug (a drug that has not been approved by the Food and Drug Administration [FDA] for use outside of research studies) known as MET642 is safe and effective in the treatment for NASH.

The purpose of this study is to learn about the effects of a study drug, MET642, to find the best dose for treating NASH, and to see how safe the MET642 is for participants with NASH. In this study, MET642 will be compared to placebo. 

You may qualify if:

  • You are 18-75 years old

ME168-5379-642201NP

Possible Treatment for Non-alcoholic Steatohepatitis (NASH)

The purpose of the study is to determine how safe and effective this study medication is when administered orally by tablet once daily for 84 days (12 weeks). We will also be evaluating the safety and effectiveness of the study medication when taken with empagliflozin (Jardience) in some participants. Jardience is an FDA approved drug used to improve glycemic control in adults with type 2 diabetes. 

The study medication is being evaluated for a possible treatment for Non-alcoholic steatohepatitis (NASH). NASH is a key cause of chronic liver disease and liver-related medical conditions. Many are not aware that they have NASH although diagnosis can be done through laboratory testing and procedures.  

You may qualify if:

  • You are 18-75 years old
  • You have been diagnosed with type 2 diabetes

ME168-5389-MET409

Measure Target Gene Expression in The Liver

This is a multisite study to qualify narrow gauge CNB as an effective method for measuring target gene expression in the liver through sample collection and analysis. The study does not involve administration of any investigational drug product.

You may qualify if:

  • You are 18-75 years old
  • You have a documented history of NASH or clinical suspicion of NASH

RE128-5366-CES1945

Study how well the Dexcom® Continuous Glucose Monitoring (CGM) System works and how it affects your daily activities

The purpose of this study is to see how well the investigational Dexcom CGM System works, and how safe it is during activities of daily living when worn for up to 10.5 days. The System may be tested both while you are at home and when you are in the clinic. While at home and at the clinic, the Sensor will store your sugar readings in the transmitter.

To take part in this study:
• You must be 18 years of age or older
• You must be diagnosed with type 1 or type 2 diabetes mellitus

Now Enrolling Adults with Type 2 Diabetes for a Paid Research Study

ProSciento is looking for adults diagnosed with type 2 diabetes to take part in a paid clinical research study in San Diego, California.

Participants will receive full compensation if all study visits are completed. Travel reimbursements are also available for study participants who do not live in the southern California area. Hotel accommodations and airfare may be provided by ProSciento for those who qualify.

The study includes up to a 32-night stay at our clinical research center in San Diego, California. Additional details will be provided during your phone call with our highly-trained team members.

All study related activities will be provided to you at no cost.

This study medication class has been proven to effectively promote a healthy weight in individuals who are overweight and control blood sugar in those who have type 2 diabetes. We are exploring a new oral dose of this type of study medication.

This study will provide information on how daily administration of the study medication is absorbed, broken down, and tolerated by the body. The study medication is a possible treatment for type 2 diabetes and/or obesity.

You may qualify if you are:

  • Currently living with type 2 diabetes
  • Between 18 and 70 years old

RR166-5396-102 MAD

Now Accepting Volunteers for Type 2 Diabetes Study

About: ProSciento is currently looking for volunteers for a new Type 2 diabetes research study. You may receive a stipend up to $2,325 for your time.  Up to 5 outpatient visits and 2 inhouse stays may be required. You may also be considered for future research studies at ProSciento. Our research facility is located in Chula Vista, California.

You may qualify if you are:

  • 21 to 75 years old
  • Diagnosed with Type 2 diabetes

Qualified volunteers may receive:

  • A stipend up to $2,325 for your time
  • Consideration for research studies at ProSciento